NTRA Natera, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 7, 2026
$410,35
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$160,5952tyg. minimum
$427,4752tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$58.93B
P/E (TTM)
-304.0
EPS (TTM)
$-1.35
Przychody (TTM)
$2.71B
Twoje odznaki
Zakres 52 tyg.
$161–$427
Ocena Analityków
BUY
Cena Docelowa
$353
P/E
-304.0
ROE
-12.5%
Marża Zysku Netto
-7.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
NTRA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$410.35
Kapitalizacja Rynkowa (MRQ)
$58.93B
P/E (TTM)
-304.0
EPS (TTM)
$-1.35
Przychody (TTM)
$2.71B
ROE (TTM)
-12.5%
D/E Dług/Kapitał (MRQ)
0.0
Zakres 52 tyg.
$161–$427
NTRA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Natera, Inc. - Common Stock Przegląd firmy z Wikipedii
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
History
Natera (previously Gene Security Network) was founded by Matthew Rabinowitz and Jonathan Sheena in 2004. Natera launched its first product, the Spectrum preimplantation genetic test, in 2009.
In 2010, the company introduced the Anora miscarriage (POC) test. Natera's advanced carrier screening test, Horizon, launched in 2012. The following year, 2013, Natera launched the Panorama non-invasive prenatal test (NIPT).
In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA."
In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only. The Signatera CLIA test was introduced for clinical use in 2019.
In 2018 Natera paid a $11 million fine to the department over allegations of improper billing and sales of Panorama to federal Healthcare services between the years of 2013 to 2016.
Natera launched the Prospera dd-cfDNA transplant assessment test in 2019, and the Renasight kidney gene panel and the Empower hereditary cancer test in 2020.
As of May 2021, Natera has performed over 3 million cell-free DNA tests. Natera's technology has also been written about in over 200 peer-reviewed journals and publications, including Nature, Science Magazine, and the Journal of Clinical Oncology.
Products and services
Women's health
The Panorama NIPT is the only single-nucleotide polymorphism (SNP)-based NIPT. The test analyzes fetal DNA found in the mother's blood to reveal a baby's risk for genetic disorders such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18) as early as nine weeks. Panorama also tests for unique microdeletions and is the only test that can detect zygosity and fetal sex in twins.
Natera also offers Horizon, a carrier-screening test that uses next-generation sequencing to provide carrier status for up to 274 genetic conditions. Additionally, Natera offers the Anora products of conception (POC) miscarriage test, the Spectrum preimplantation genetic screening and diagnosis test, and the Vistara single-gene prenatal screening test. In 2020, Natera launched Empower, a hereditary cancer test that screens for up to 53 genes associated with increased risk for common hereditary cancers.
Oncology
Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and cancer recurrence monitoring. In 2020, Signatera received the CE Mark, as well as final Medicare coverage in stage II-III colorectal cancer and draft coverage in immunotherapy response monitoring. Signatera has been clinically validated to detect colorectal cancer recurrence up to 16.5 months in advance of radiologic imaging and early-stage breast cancer up to two years earlier than imaging.
Organ health
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Constellation
Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealthcare
branżaBiotechnology
pracownicy6 135
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$2.31B2016-12-31 → 2025-12-31
EPS$-1.522016-12-31 → 2025-12-31
Wolny przepływ pieniężny$109M2016-12-31 → 2025-12-31
Marża netto-7.1%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | NTRA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -304.0średnia z 5 lat ≈-59.2 | ≈-59.2 | · | · | |
| P/S (TTM) | 21.8średnia z 5 lat ≈10.6 | ≈10.6 | 7.3 | Zawyżona wycena | |
| P/B (MRQ) | 32.4średnia z 5 lat ≈13.2 | ≈13.2 | 6.2 | Zawyżona wycena | |
| Cena / FCF (TTM) | 699.9średnia z 5 lat ≈107.5 | ≈107.5 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 258.2średnia z 5 lat ≈47.2 | ≈47.2 | 18.3 | Zawyżona wycena | |
| Cena / Wartość księgowa materialna (MRQ) | 40.3średnia z 5 lat ≈14.8 | ≈14.8 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | NTRA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -10.7%średnia z 5 lat ≈-41.7% | ≈-41.7% | 24.0% | Słaby | |
| Marża EBITDA (TTM) | -8.8%średnia z 5 lat ≈-39.8% | ≈-39.8% | 17.9% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -9.3%średnia z 5 lat ≈-41.0% | ≈-41.0% | 13.8% | Słaby | |
| Marża Zysku Netto (TTM) | -7.1%średnia z 5 lat ≈-40.5% | ≈-40.5% | 12.7% | Słaby | |
| ROA (TTM) | -8.7%średnia z 5 lat ≈-27.7% | ≈-27.7% | 11.5% | Słaby | |
| ROE (TTM) | -12.5%średnia z 5 lat ≈-51.6% | ≈-51.6% | 18.7% | Słaby | |
| ROIC | -13.4%średnia z 5 lat ≈-43.9% | ≈-43.9% | 17.3% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | NTRA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.0średnia z 5 lat ≈0.1 | ≈0.1 | 0.1 | Niski dług | |
| Wskaźnik bieżący (MRQ) | 3.0średnia z 5 lat ≈4.1 | ≈4.1 | 3.2 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.7średnia z 5 lat ≈2.3 | ≈2.3 | 2.5 | Niska płynność | |
| Interest Coverage (Pokrycie odsetek) | -76.2średnia z 5 lat ≈-49.3 | ≈-49.3 | 8.1 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | NTRA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 35.9%średnia z 5 lat ≈43.1% | ≈43.1% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 41.1%średnia z 5 lat ≈40.3% | ≈40.3% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 42.6% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | NTRA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.1średnia z 5 lat ≈0.8 | ≈0.8 | 0.5 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 7.6średnia z 5 lat ≈5.6 | ≈5.6 | 6.4 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$375.9K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
17.2%
Następny raport
Lis 04, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 5, 2026 | $-0.47 | $-0.50 | 6.7% |
| 31 marca 2026 | Maj 7, 2026 | $-0.60 | $-0.55 | -9.7% |
| 31 grudnia 2025 | $0.36 | $-0.52 | 169.1% | |
| 30 września 2025 | $-0.64 | $-0.38 | -68.2% | |
| 30 czerwca 2025 | $-0.74 | $-0.63 | -17.8% | |
| 31 marca 2025 | $-0.50 | $-0.65 | 23.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | $159M | |
| Cost of Revenue | · | · | · | · | · | · | · | $158M | $136M | $134M | $113M | $78M | |
| R&D Expense | $624M | $404M | $321M | $316M | $264M | $100M | $51M | $51M | $50M | $42M | $28M | $17M | |
| SG&A Expense | $1.18B | $841M | $618M | $589M | $511M | $304M | $206M | $155M | $155M | $136M | $110M | $63M | |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607M | $419M | $372M | $345M | $314M | $250M | $159M | |
| Operating Income | $-310M | $-222M | $-446M | $-541M | $-468M | $-216M | $-116M | $-115M | $-135M | $-101M | $-60M | $665.0K | |
| Interest Expense | $4M | $11M | $13M | $9M | $8M | $15M | $11M | $10M | $4M | $533.0K | $4M | $4M | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $-8M | $-2M | |
| Pretax Income | $-268M | $-190M | $-435M | $-547M | $-471M | $-230M | $-123M | $-128M | $-137M | $-100M | $-70M | $-5M | |
| Income Tax | $-60M | $695.0K | $271.0K | $978.0K | $618.0K | $98.0K | $2M | $321.0K | $454.0K | $142.0K | · | $15.0K | |
| Net Income | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | $-5M | |
| EPS (Basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.58 | $-1.95 | $-2.68 | · | |
| EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · | |
| Shares (Basic) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,312,000 | 51,576,000 | 26,204,000 | · | |
| Shares (Diluted) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,604,000 | 51,576,000 | 26,204,000 | · | |
| EBITDA | $-268M | $-191M | $-422M | $-524M | $-457M | $-208M | $-109M | $-107M | $-127M | $-90M | $-54M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | |
| Short-term Investments | · | $23M | $237M | $432M | $830M | $689M | $379M | $107M | $106M | $131M | $202M | · | |
| Receivables | $297M | $314M | $278M | $244M | $122M | $79M | $53M | $62M | $44M | $13M | $6M | $6M | |
| Inventory | $68M | $45M | $41M | $35M | $27M | $20M | $12M | $14M | $9M | $6M | $8M | $12M | |
| Prepaid Expense | $56M | $49M | $61M | $34M | $30M | $27M | $16M | $6M | $9M | $7M | $5M | $1M | |
| Current Assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $863M | $523M | $241M | $181M | $174M | $251M | $106M | |
| PP&E (Net) | $241M | $162M | $111M | $92M | $66M | $33M | $23M | $24M | $30M | $32M | $13M | $15M | |
| PP&E (Gross) | $352M | $240M | $168M | $128M | $85M | $83M | $65M | $59M | $57M | $52M | $26M | $24M | |
| Accum. Depreciation | $111M | $78M | $56M | $36M | $19M | $50M | $42M | $34M | $27M | $19M | $14M | $10M | |
| Goodwill | $141M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $374M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $37M | $26M | $15M | $18M | $19M | $15M | $12M | $3M | $4M | $4M | $1M | $2M | |
| Total Assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Accounts Payable | $33M | $35M | $15M | $31M | $27M | $8M | $9M | $15M | $9M | $11M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | · | $60M | $49M | $32M | $33M | $20M | $19M | $10M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Current Liabilities | $441M | $344M | $307M | $310M | $219M | $199M | $180M | $114M | $106M | $96M | $80M | $30M | |
| Capital Leases | $118M | $97M | $67M | $77M | $61M | $21M | $26M | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $8M | · | · | $1M | $320.0K | $310.0K | · | $1M | · | · | · | |
| Total Liabilities | $686M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $54M | |
| Long-term Debt | · | · | $283M | $282M | $280M | · | · | · | · | · | · | · | |
| Total Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Common Stock | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-2.78B | $-2.57B | $-2.38B | $-1.94B | $-1.39B | $-929M | $-699M | $-575M | $-446M | $-346M | $-250M | $-180M | |
| AOCI | $-258.0K | $-344.0K | $-3M | $-16M | $-2M | $4M | $919.0K | $-552.0K | $-766.0K | $-725.0K | $-1M | · | |
| Stockholders' Equity | $1.71B | $1.20B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $144M | $226M | $-171M | |
| Liabilities + Equity | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Shares Outstanding | 139,693,000 | 132,646,000 | 119,581,000 | 111,255,000 | 95,140,000 | 86,223,000 | 78,005,000 | 62,083,000 | 54,040,000 | 52,665,000 | 50,346,000 | 6,879,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $31M | $24M | $17M | $11M | $9M | $8M | $8M | $7M | $6M | $6M | $5M | |
| Stock-based Comp | $354M | $274M | $192M | $152M | $115M | $50M | $29M | $14M | $11M | $11M | $7M | $5M | |
| Amort. of Intangibles | $4M | $1M | $0 | · | · | · | $1M | $1M | $1M | $600.0K | $200.0K | $0 | |
| Restructuring | · | · | · | · | $400.0K | $400.0K | · | · | · | · | · | · | |
| Other Non-cash | $27M | $21M | $-28M | $-53M | $10M | $-12M | $25M | $36M | $21M | $5M | $20M | · | |
| Operating Cash Flow | $215M | $136M | $-247M | $-432M | $-335M | $-183M | $-63M | $-71M | $-98M | $-74M | $-38M | $10M | |
| CapEx | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | |
| Investing Cash Flow | $-132M | $138M | $168M | $330M | $-205M | $-331M | $-266M | $-5M | $14M | $47M | $-211M | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Financing Cash Flow | $47M | $30M | $254M | $483M | $576M | $501M | $341M | $114M | $80M | $13M | $190M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-14M | $-58M | · | |
| Taxes Paid | $499.0K | $1M | $295.0K | $549.0K | $283.0K | $67.0K | $2M | $332.0K | $177.0K | · | · | · | |
| Free Cash Flow | $109M | $69M | $-286M | $-479M | $-376M | $-202M | $-68M | $-74M | $-107M | $-97M | $-46M | · | |
| Levered FCF | $106M | $59M | $-299M | $-489M | $-385M | $-217M | $-79M | $-85M | $-111M | $-98M | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | · | |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | · | |
| Pretax Margin | -11.6% | -11.2% | -40.1% | -66.7% | -75.3% | -58.7% | -40.6% | -49.6% | -64.4% | -44.0% | · | · | |
| EBITDA Margin | -11.6% | -11.3% | -39.0% | -63.9% | -73.0% | -53.1% | -35.9% | -41.6% | -60.2% | -41.6% | -28.5% | · | |
| ROA | -10.3% | -12.3% | -30.7% | -41.6% | -43.5% | -30.3% | -29.3% | -53.1% | -70.0% | -40.2% | -36.1% | · | |
| ROE | -14.1% | -18.4% | -56.1% | -102.6% | -66.8% | -45.0% | -68.7% | -288.9% | -204.7% | -57.5% | -1046.5% | · | |
| ROIC | -13.4% | -17.5% | -52.8% | -69.0% | -66.6% | -40.4% | -35.9% | -139.6% | -338.4% | -61.9% | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 | 4.3 | 2.9 | 2.1 | 1.4 | 1.8 | 3.1 | · | |
| Quick Ratio | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 | 4.1 | 2.7 | 1.9 | 1.2 | 1.7 | 2.9 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 1.6 | -4.8 | 0.5 | 0.2 | · | |
| Interest Coverage | -76.2 | -20.8 | -35.3 | -58.1 | -56.4 | -14.3 | -10.9 | -10.9 | -31.8 | -181.0 | -17.1 | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 0.8 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.1 | 0.9 | 1.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 14.0 | 17.6 | 18.7 | 11.5 | · | |
| Receivables Turnover | 7.6 | 5.7 | 4.1 | 4.5 | 6.2 | 5.9 | 5.2 | 4.8 | 19.5 | 22.5 | 32.3 | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.26 | $9.01 | $6.40 | $6.34 | $6.87 | $5.64 | $3.57 | $0.52 | $-0.19 | $2.02 | $3.67 | · | |
| Revenue / Share | $16.87 | $13.61 | $9.41 | $8.33 | $6.91 | · | $4.35 | $4.45 | $3.94 | · | · | · | |
| Cash Flow / Share | $1.57 | $1.09 | $-2.15 | $-4.38 | $-3.70 | · | $-0.91 | $-1.22 | $-1.81 | · | · | · | |
| Cash / Share | · | · | · | $4.19 | $0.89 | $0.56 | $0.79 | $0.75 | $0.23 | $0.29 | $0.57 | · | |
| EPS (TTM) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 35.9% | 56.8% | 32.0% | 31.1% | 60.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 41.1% | 39.5% | 40.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 42.6% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | · | |
| Net Income TTM | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | · | |
| Market Cap | $32.00B | $21.00B | $7.49B | $4.47B | $8.89B | $8.58B | $2.63B | $867M | $486M | $617M | $544M | · | |
| Enterprise Value | · | · | · | $3.65B | $8.02B | $7.89B | $2.24B | $763M | $417M | $520M | $355M | · | |
| P/E | -150.7 | -103.5 | -16.6 | -7.2 | -17.9 | -35.0 | -18.8 | -6.3 | -3.5 | -6.0 | -4.0 | · | |
| P/S | 13.9 | 12.4 | 6.9 | 5.4 | 14.2 | 21.9 | 8.7 | 3.4 | 2.3 | 2.9 | 2.9 | · | |
| P/B | 18.7 | 17.6 | 9.8 | 6.3 | 13.6 | 17.6 | 9.4 | 26.9 | -46.8 | 5.8 | 2.9 | · | |
| P / Tangible Book | 26.7 | 17.7 | 9.8 | 6.3 | 13.6 | 17.6 | · | · | · | · | · | · | |
| P / Cash Flow | 148.6 | 154.8 | -30.3 | -10.4 | -26.5 | -47.0 | -41.4 | -12.3 | -5.0 | -8.3 | -14.4 | · | |
| P / FCF | 293.3 | 303.3 | -26.2 | -9.3 | -23.6 | -42.5 | -38.4 | -11.6 | -4.6 | -6.4 | -11.9 | · | |
| EV / EBITDA | · | · | · | -7.0 | -17.6 | -38.0 | -20.6 | -7.1 | -3.3 | -5.8 | -6.5 | · | |
| EV / FCF | · | · | · | -7.6 | -21.3 | -39.1 | -32.7 | -10.2 | -3.9 | -5.4 | -7.8 | · | |
| EV / Revenue | · | · | · | 4.5 | 12.8 | 20.2 | 7.4 | 3.0 | 2.0 | 2.4 | 1.9 | · | |
| Earnings Yield | -0.66% | -0.97% | -6.0% | -13.9% | -5.6% | -2.9% | -5.3% | -15.9% | -28.8% | -16.7% | -24.8% | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M | $368M | $311M | $268M | $261M | $242M | $217M | $211M | |
| R&D Expense | $228M | $211M | $175M | $173M | $146M | $129M | $129M | $97M | $89M | $89M | $83M | $77M | $78M | $82M | $88M | $66M | |
| SG&A Expense | $327M | $328M | $291M | $309M | $311M | $267M | $235M | $214M | $198M | $194M | $161M | $155M | $153M | $150M | $144M | $148M | |
| Operating Expenses | $829M | $790M | $688M | $690M | $657M | $581M | $541M | $479M | $457M | $442M | $396M | $379M | $374M | $380M | $359M | $330M | |
| Operating Income | $-76M | $-94M | $-23M | $-98M | $-110M | $-79M | $-65M | $-39M | $-44M | $-74M | $-85M | $-111M | $-112M | $-138M | $-142M | $-119M | |
| Interest Expense | · | · | $990.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Other Non-op | $9M | $10M | · | · | $11M | $13M | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-67M | $-85M | $-13M | $-87M | $-101M | $-67M | $-55M | $-31M | $-37M | $-67M | $-78M | $-109M | $-111M | $-137M | $-142M | $-121M | |
| Income Tax | $-261.0K | $283.0K | $-61M | $207.0K | $275.0K | $173.0K | $-1M | $730.0K | $892.0K | $428.0K | $191.0K | $202.0K | $-282.0K | $160.0K | $421.0K | $185.0K | |
| Net Income | $-67M | $-85M | $47M | $-88M | $-101M | $-67M | $-54M | $-32M | $-37M | $-68M | $-78M | $-109M | $-111M | $-137M | $-143M | $-121M | |
| EPS (Basic) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| EPS (Diluted) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| Shares (Basic) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| Shares (Diluted) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| EBITDA | $-76M | $-79M | · | $-98M | $-110M | $-70M | · | $-39M | $-44M | $-67M | · | $-111M | $-112M | $-133M | · | $-119M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $57M | |
| Short-term Investments | · | · | · | $1M | $16M | $18M | $23M | $29M | $90M | $69M | · | $268M | $355M | $409M | · | $464M | |
| Receivables | $422M | $418M | $297M | $286M | $309M | $318M | $314M | $307M | $336M | $289M | · | $255M | $260M | $247M | · | $236M | |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M | $41M | $43M | · | $42M | $43M | $41M | · | $40M | |
| Prepaid Expense | $65M | $76M | $56M | $54M | $52M | $56M | $49M | $45M | $38M | $47M | · | $33M | $27M | $30M | · | $32M | |
| Current Assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B | $1.30B | $1.26B | · | $1.27B | $1.07B | $1.13B | · | $830M | |
| PP&E (Net) | $318M | $269M | $241M | $206M | $189M | $180M | $162M | $142M | $133M | $126M | · | $105M | $103M | $101M | · | $87M | |
| PP&E (Gross) | $451M | $390M | $352M | $307M | $281M | $267M | $240M | $213M | $198M | $185M | · | $155M | $148M | $141M | · | $119M | |
| Accum. Depreciation | $133M | $120M | $111M | $101M | $92M | $87M | $78M | $71M | $64M | $59M | · | $51M | $45M | $41M | · | $31M | |
| Goodwill | $141M | $141M | $141M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $360M | $367M | $374M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $50M | $51M | $37M | $71M | $41M | $41M | $26M | $38M | $29M | $26M | · | $16M | $18M | $19M | · | $18M | |
| Total Assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Accounts Payable | $75M | $62M | $33M | $46M | $37M | $39M | $35M | $28M | $33M | $26M | · | $21M | $21M | $36M | · | $34M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Current Liabilities | $553M | $558M | $441M | $442M | $385M | $366M | $344M | $301M | $315M | $306M | · | $290M | $277M | $291M | · | $267M | |
| Capital Leases | $143M | $145M | $118M | $104M | $103M | $103M | $97M | $99M | $61M | $64M | · | $68M | $71M | $74M | · | $78M | |
| Other Non-current Liabilities | $25M | $16M | $12M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M | $680M | $674M | · | $662M | $652M | $668M | · | $647M | |
| Total Debt | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $11.0K | $11.0K | $11.0K | · | $10.0K | |
| Retained Earnings | $-2.93B | $-2.86B | $-2.78B | $-2.82B | $-2.74B | $-2.63B | $-2.57B | $-2.51B | $-2.48B | $-2.45B | · | $-2.30B | $-2.19B | $-2.08B | · | $-1.80B | |
| AOCI | $-108.0K | $-202.0K | $-258.0K | $-187.0K | $-287.0K | $-197.0K | $-344.0K | $-765.0K | $-1M | $-2M | $-3M | $-5M | $-9M | $-12M | $-16M | $-20M | |
| Stockholders' Equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M | $837M | $794M | $765M | $785M | $596M | $651M | $706M | $362M | |
| Liabilities + Equity | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Shares Outstanding | 143,612,000 | 142,734,000 | 139,693,000 | 137,533,000 | 136,757,000 | 135,932,000 | 132,646,000 | 124,137,000 | 123,365,000 | 122,234,000 | · | 118,990,000 | 114,051,000 | 113,359,000 | · | 97,300,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $15M | $12M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $4M | $5M | |
| Stock-based Comp | $103M | $95M | $93M | $91M | $93M | $78M | $72M | $71M | $67M | $64M | $49M | $57M | $44M | $40M | $36M | $40M | |
| Amort. of Intangibles | $6M | $7M | · | · | $0 | $300.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $16M | · | · | · | $24M | · | · | · | $23M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M | $27M | $-58M | $-30M | $-79M | $-81M | $-81M | $-102M | |
| CapEx | $63M | $22M | $36M | $22M | $26M | $22M | $18M | $16M | $12M | $20M | $10M | $9M | $9M | $11M | $12M | $12M | |
| Investing Cash Flow | $-63M | $-32M | $-72M | $-20M | $-24M | $-17M | $-11M | $43M | $-32M | $138M | $24M | $82M | $47M | $16M | $22M | $67M | |
| Financing Cash Flow | $12M | $4M | $32M | $2M | $13M | $544.0K | $11M | $2M | $11M | $6M | $7M | $236M | $9M | $2M | $468M | $1M | |
| Net Change in Cash | $4M | $12M | · | · | $26M | $28M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $18M | · | · | · | $23M | · | · | · | $7M | · | · | · | $-92M | · | · | |
| Levered FCF | · | · | · | · | · | $22M | · | · | · | $4M | · | · | · | $-96M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.1% | -13.4% | · | -16.5% | -20.2% | -15.8% | · | -8.9% | -10.6% | -20.2% | · | -41.4% | -43.0% | -57.2% | · | -56.5% | |
| Net Margin | -8.9% | -12.2% | · | -14.8% | -18.5% | -13.3% | · | -7.2% | -9.1% | -18.4% | · | -40.6% | -42.4% | -56.6% | · | -57.7% | |
| Pretax Margin | -8.9% | -12.2% | · | -14.8% | -18.4% | -13.3% | · | -7.0% | -8.8% | -18.3% | · | -40.6% | -42.5% | -56.6% | · | -57.6% | |
| EBITDA Margin | -10.1% | -11.3% | · | -16.5% | -20.2% | -13.9% | · | -8.9% | -10.6% | -18.3% | · | -41.4% | -43.0% | -55.1% | · | -56.5% | |
| ROA | -3.0% | -3.9% | · | -5.1% | -6.2% | -4.2% | · | -2.1% | -2.7% | -4.9% | · | -8.9% | -9.6% | -11.1% | · | -10.5% | |
| ROE | -4.4% | -5.7% | · | -8.2% | -9.7% | -6.6% | · | -3.8% | -5.2% | -9.4% | · | -19.0% | -21.3% | -23.0% | · | -21.7% | |
| ROIC | -4.0% | -5.1% | · | -7.3% | -8.3% | -6.0% | · | -4.2% | -4.9% | -8.6% | · | -12.8% | -16.6% | -18.9% | · | -29.0% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.0 | · | 3.3 | 3.7 | 3.9 | · | 4.4 | 4.1 | 4.1 | · | 4.4 | 3.8 | 3.9 | · | 3.1 | |
| Quick Ratio | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.4 | 1.2 | · | 1.8 | 2.2 | 2.3 | · | 2.8 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | -93.4 | -107.3 | -78.8 | · | -12.5 | -14.0 | -23.8 | · | -34.1 | -35.4 | -45.2 | · | -51.1 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 1.9 | · | 2.0 | 1.7 | 1.7 | · | 1.6 | 1.4 | 1.4 | · | 1.1 | 1.1 | 1.2 | · | 1.2 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.68 | $12.43 | · | $9.10 | $9.11 | $9.12 | · | $7.08 | $6.78 | $6.50 | · | $6.59 | $5.23 | $5.74 | · | $3.72 | |
| Revenue / Share | $5.25 | $4.92 | · | $4.32 | $4.01 | $3.72 | · | $3.55 | $3.36 | $3.04 | · | $2.33 | $2.30 | $2.16 | · | $2.17 | |
| Cash Flow / Share | · | $0.28 | · | · | · | $0.33 | · | · | · | $0.22 | · | · | · | $-0.72 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.59 | |
| EPS (TTM) | $-1.35 | $-1.62 | · | $-2.29 | $-1.91 | $-1.47 | · | $-1.75 | $-2.44 | $-3.11 | · | $-4.52 | $-4.82 | $-5.35 | · | $-5.72 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.71B | $2.50B | · | $2.12B | $1.96B | $1.83B | · | $1.53B | $1.36B | $1.21B | · | $989M | $931M | $868M | · | $776M | |
| Net Income TTM | $-192M | $-226M | · | $-309M | $-253M | $-190M | · | $-215M | $-292M | $-365M | · | $-499M | $-512M | $-546M | · | $-546M | |
| Market Cap | $38.98B | $28.55B | · | $22.14B | $23.10B | $19.22B | · | $15.76B | $13.36B | $11.18B | · | $5.27B | $5.55B | $6.29B | · | $4.26B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.79B | |
| P/E | -201.1 | -123.5 | · | -70.3 | -88.5 | -96.2 | · | -72.5 | -44.4 | -29.4 | · | -9.8 | -10.1 | -10.4 | · | -7.7 | |
| P/S | 14.4 | 11.4 | · | 10.5 | 11.8 | 10.5 | · | 10.3 | 9.8 | 9.3 | · | 5.3 | 6.0 | 7.3 | · | 5.5 | |
| P/B | 21.4 | 16.1 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Tangible Book | 29.5 | 22.6 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Cash Flow | · | 710.6 | · | · | · | 432.4 | · | · | · | 414.0 | · | · | · | -77.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 4.9 | |
| Earnings Yield | -0.50% | -0.81% | · | -1.4% | -1.1% | -1.0% | · | -1.4% | -2.2% | -3.4% | · | -10.2% | -9.9% | -9.6% | · | -13.1% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $2.31B | $1.70B | $1.08B | $820M | $625M |
| Marża Operacyjna % | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% |
| Zysk netto | $-208M | $-190M | $-435M | $-548M | $-472M |
| Rozwodniony EPS | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Wskaźnik bieżący | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 |
| Wskaźnik Szybkości | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $109M | $69M | $-286M | $-479M | $-376M |
Właściciele instytucjonalni (13F) 928 emitentów · $36.5B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
928
Wartość posiadanych akcji
$36.5B
Nowe pozycje
166
Zamknięte pozycje
63
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 166 (+55 vs poprzedni kw.) | 63 (-37 vs poprzedni kw.) | 359 (+56 vs poprzedni kw.) | 247 (-14 vs poprzedni kw.) | +8.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | $3 505 094 525 | 12 865 346 | 9,61% | Akcje |
| BlackRock, Inc. | $2 962 770 331 | 10 914 608 | 8,12% | Akcje |
| VANGUARD GROUP INC | $2 819 278 675 | 12 306 424 | 7,73% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 690 649 234 | 6 228 216 | 4,63% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 569 697 628 | 5 782 640 | 4,30% | Akcje |
| FMR LLC | $1 479 781 281 | 5 451 396 | 4,06% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $1 096 858 330 | 4 040 738 | 3,01% | Akcje |
| STATE STREET CORP | $992 317 506 | 3 655 618 | 2,72% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $744 565 293 | 2 750 013 | 2,04% | Akcje |
| FRANKLIN RESOURCES INC | $739 946 472 | 2 725 903 | 2,03% | Akcje |
| Castle Hook Partners LP | $704 759 120 | 2 596 276 | 1,93% | Akcje |
| COATUE MANAGEMENT LLC | $680 006 681 | 2 505 090 | 1,86% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $628 086 698 | 2 344 570 | 1,72% | Akcje |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $602 175 451 | 2 218 366 | 1,65% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $535 084 922 | 1 971 391 | 1,47% | Akcje |
| NORGES BANK | $496 243 717 | 1 828 122 | 1,36% | Akcje |
| FRED ALGER MANAGEMENT, LLC | $482 640 543 | 1 778 009 | 1,32% | Akcje |
| GOLDMAN SACHS GROUP INC | $466 935 338 | 1 720 152 | 1,28% | Akcje |
| Sofinnova Investments, Inc. | $420 823 506 | 1 550 280 | 1,15% | Akcje |
| Capital World Investors | $408 365 851 | 1 504 387 | 1,12% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $408 180 994 | 1 503 706 | 1,12% | Akcje |
| MAVERICK CAPITAL LTD | $368 266 171 | 1 356 663 | 1,01% | Akcje |
| D. E. Shaw & Co., Inc. | $347 253 770 | 1 279 255 | 0,95% | Akcje |
| MORGAN STANLEY | $345 906 057 | 1 274 287 | 0,95% | Akcje |
| FEDERATED HERMES, INC. | $309 172 863 | 1 138 968 | 0,85% | Akcje |
| Clearbridge Investments, LLC | $276 424 438 | 1 018 325 | 0,76% | Akcje |
| RTW INVESTMENTS, LP | $271 450 000 | 1 000 000 | 0,74% | Akcje |
| JANE STREET GROUP, LLC | $251 630 350 | 926 986 | 0,69% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $249 356 413 | 918 609 | 0,68% | Akcje |
| Invesco Ltd. | $237 065 949 | 873 332 | 0,65% | Akcje |
| NORTHERN TRUST CORP | $227 070 096 | 836 508 | 0,62% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $218 934 197 | 806 536 | 0,60% | Akcje |
| BANK OF AMERICA CORP /DE/ | $199 960 146 | 736 637 | 0,55% | Akcje |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $197 243 187 | 726 628 | 0,54% | Akcje |
| ARK Investment Management LLC | $186 989 592 | 688 855 | 0,51% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $174 716 892 | 643 643 | 0,48% | Akcje |
| Chevy Chase Trust Holdings, LLC | $162 830 912 | 599 856 | 0,45% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $160 992 382 | 593 083 | 0,44% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $160 551 817 | 591 460 | 0,44% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $150 579 670 | 752 936 | 0,41% | Akcje |
| UBS Group AG | $150 312 452 | 553 739 | 0,41% | Akcje |
| Legal & General Group Plc | $150 142 799 | 553 114 | 0,41% | Akcje |
| Bank of New York Mellon Corp | $149 277 609 | 549 927 | 0,41% | Akcje |
| FIRST TRUST ADVISORS LP | $138 768 953 | 511 214 | 0,38% | Akcje |
| WELLS FARGO & COMPANY/MN | $136 489 991 | 502 818 | 0,37% | Akcje |
| Nuveen, LLC | $135 477 536 | 499 089 | 0,37% | Akcje |
| GILDER GAGNON HOWE & CO LLC | $135 199 396 | 498 064 | 0,37% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $129 951 802 | 478 732 | 0,36% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $125 949 543 | 463 988 | 0,35% | Akcje |
| Avala Global LP | $124 867 000 | 460 000 | 0,34% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C., Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C., Dr. Michael F. Powell (“Powell”), Dr. James I. Healy ×3 zgłoszenia | 13 lutego 2020 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 21 insiderów · 7 dyrektorzy generalni · 15 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Steven Leonard Chapman | CEO AND PRESIDENT | 1 października 2026 S | 96 926 | 0 | 54 | $-90 749 334 |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 4 sierpnia 2026 S | 51 637 | 0 | 41 | $-21 731 496 |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1 października 2026 S | 106 914 | 0 | 64 | $-23 640 470 |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 10 sierpnia 2026 S | 197 257 | 0 | 18 | $-9 345 666 |
| Robert Alan Schueren | CHIEF OPERATING OFFICER | 27 stycznia 2023 A | 24 091 | 0 | 0 | $0 |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 15 września 2026 S | 0 | 0 | 92 | $-124 045 289 |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 3 sierpnia 2026 S | 170 073 | 0 | 41 | $-23 609 158 |
| Jonathan Sheena | Dyrektor | 23 września 2026 S | 9 000 | 0 | 144 | $-29 839 868 |
| Rowan E Chapman | Dyrektor | 15 lipca 2026 S | 4 663 | 0 | 5 | $-1 764 386 |
| Eric H Rubin | Dyrektor | 26 czerwca 2026 A | 2 204 | 0 | 0 | $0 |
| Monica Bertagnolli | Dyrektor | 26 czerwca 2026 A | 7 020 | 0 | 0 | $0 |
| Gail Boxer Marcus | Dyrektor | 26 czerwca 2026 A | 7 852 | 0 | 5 | $-2 413 550 |
| Roy D. Baynes | Dyrektor | 26 czerwca 2026 A | 20 158 | 0 | 8 | $-2 809 687 |
| Thomas J. Lynch Jr. | Dyrektor | 26 czerwca 2026 A | 1 905 | 0 | 0 | $0 |
| Herm Rosenman | Dyrektor | 26 czerwca 2026 A | 5 927 | 0 | 5 | $-15 143 996 |
| ROELOF BOTHA ("RB") | Dyrektor | 26 czerwca 2026 A | 4 585 | 0 | 17 | $-34 892 929 |
| Dr. James I. Healy | Dyrektor | 25 kwietnia 2025 A | 46 260 | 0 | 0 | $0 |
| Todd C Cozzens | Dyrektor | 25 maja 2022 M | 15 813 | 0 | 0 | $0 |
| John Steuart | Dyrektor | 16 maja 2019 M | 7 278 | 0 | 0 | $0 |
| Edward C. Driscoll Jr. | Dyrektor | 16 maja 2019 M | 52 009 | 0 | 0 | $0 |
| Ruth Williams Brinkley | · | 24 kwietnia 2026 A | 5 475 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 75 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 6,29% | 63 892 SH | 2 października 2026 | Dziennie |
| ARKG · ARK ETF Trust | 4,13% | 240 145 NS | 31 lipca 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 3,82% | 26 940 SH | 2 października 2026 | Dziennie |
| IBB · iShares Trust | 3,30% | 1 043 662 SH | 11 września 2026 | Dziennie |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 2,95% | 85 185 SH | 2 października 2026 | Dziennie |
| MEDI · Harbor ETF Trust | 2,26% | 3 475 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,23% | 87 424 NS | 31 lipca 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,23% | 5 764 NS | 31 lipca 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 1,74% | 13 080 NS | 31 lipca 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 1,58% | 57 481 SH | 2 października 2026 | Dziennie |
| GURU · Global X Funds | 1,52% | 3 466 NS | 31 lipca 2026 | N-PORT |
| IWP · iShares Trust | 1,31% | 769 818 SH | 11 września 2026 | Dziennie |
| ARKK · ARK ETF Trust | 1,24% | 257 162 NS | 31 lipca 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 1,01% | 1 802 288 SH | 19 sierpnia 2026 | Dziennie |
| HQGO · Lattice Strategies Trust | 0,86% | 1 588 NS | 31 lipca 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,84% | 15 588 NS | 31 lipca 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,80% | 460 NS | 31 lipca 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,79% | 59 919 NS | 31 lipca 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,77% | 37 874 NS | 31 lipca 2026 | N-PORT |
| TEXN · iShares Trust | 0,74% | 426 SH | 11 września 2026 | Dziennie |
| IYH · iShares Trust | 0,72% | 79 898 SH | 11 września 2026 | Dziennie |
| IMCG · iShares Trust | 0,62% | 75 541 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,54% | 404 713 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,52% | 64 051 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,44% | 1 643 356 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,44% | 3 120 454 SH | 19 sierpnia 2026 | Dziennie |
| LQAI · Exchange Listed Funds Trust | 0,41% | 34 NS | 31 lipca 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,38% | 8 233 NS | 31 lipca 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,36% | 20 763 NS | 31 lipca 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,35% | 9 234 NS | 31 lipca 2026 | N-PORT |
| IWR · iShares Trust | 0,33% | 559 634 SH | 11 września 2026 | Dziennie |
| SIZE · iShares Trust | 0,32% | 4 182 SH | 11 września 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,31% | 20 376 SH | 2 października 2026 | Dziennie |
| IMCB · iShares Trust | 0,31% | 15 983 SH | 11 września 2026 | Dziennie |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 27 638 NS | 31 lipca 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,24% | 213 NS | 31 lipca 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,20% | 12 005 SH | 11 września 2026 | Dziennie |
| ILCG · iShares Trust | 0,14% | 13 232 SH | 11 września 2026 | Dziennie |
| IWF · iShares Trust | 0,14% | 513 245 SH | 11 września 2026 | Dziennie |
| VEGN · ETF Series Solutions | 0,12% | 801 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,12% | 2 318 SH | 2 października 2026 | Dziennie |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 132 NS | 31 lipca 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 216 186 SH | 19 sierpnia 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 7 532 SH | 19 sierpnia 2026 | Dziennie |
| HAPI · Harbor ETF Trust | 0,10% | 1 778 NS | 31 lipca 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,08% | 23 570 SH | 2 października 2026 | Dziennie |
| USCL · iShares Trust | 0,08% | 7 220 SH | 11 września 2026 | Dziennie |
| GARP · iShares Trust | 0,07% | 7 023 SH | 11 września 2026 | Dziennie |
| ILCB · iShares Trust | 0,07% | 2 633 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,07% | 6 130 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,06% | 187 328 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,06% | 95 076 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,06% | 37 512 SH | 11 września 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,06% | 30 869 SH | 19 sierpnia 2026 | Dziennie |
| BKLC · BNY Mellon ETF Trust | 0,06% | 11 523 NS | 31 lipca 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,06% | 2 309 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,05% | 42 084 NS | 31 lipca 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,05% | 11 689 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,05% | 379 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,05% | 4 321 128 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,05% | 22 505 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,05% | 11 503 SH | 19 sierpnia 2026 | Dziennie |
| TOV · EA Series Trust | 0,05% | 479 NS | 31 lipca 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 11 995 SH | 11 września 2026 | Dziennie |
| CRBN · iShares Trust | 0,05% | 1 666 SH | 11 września 2026 | Dziennie |
| ACWI · iShares Trust | 0,04% | 42 227 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,04% | 3 402 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 3 537 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,04% | 18 510 NS | 31 lipca 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 113 866 SH | 19 sierpnia 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,03% | 3 396 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 42 957 NS | 31 lipca 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,02% | 132 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1 514 SH | 2 października 2026 | Dziennie |
| SMLF · iShares Trust | · | 96 755 SH | 11 września 2026 | Dziennie |
NTRA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 30 analityków
KUP
Średni cel
$360.00
-12,3%
12 40,0%
Mocne kupno
14 46,7%
Kup
4 13,3%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
23 analityków · 2026-09-28Średnia cel $352.80 -14,0%
Teraz
Aktualna cena $410.35
Niski$280.00
Średnia$352.80
Wysoki$460.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | · |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | · |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | · |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | · |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | · |
| RVMD | · | · | · | · | · | · |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | · |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | · |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | · |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Natera Inc. (NTRA): Wybór akcji miliardera Toma Steyera z ogromnym potencjałem wzrostu
Yahoo Finance · 4 miesiące, 4 tygodnie temu
Stanley Druckenmiller Zrealizował 1 Dużą Inwestycję, Która Nadal Wygląda Atrakcyjnie Dziś i Zmniejszył 2 Najlepsze Pozycje
Yahoo Finance · 5 miesięcy, 2 tygodnie temu
Natera Inc. (NTRA): Potencjał wzrostu przyciąga miliardera Stan Druckenmiller
Yahoo Finance · 5 miesięcy, 3 tygodnie temu
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 7, 2026